Chunjing Wang

ORCID: 0009-0008-4350-0618
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Metastasis and carcinoma case studies
  • Gastric Cancer Management and Outcomes
  • Gastrointestinal Tumor Research and Treatment

Harbin Medical University
2023

Second Affiliated Hospital of Harbin Medical University
2023

This study aimed to evaluate the efficacy and safety of neoadjuvant programmed cell death-1 (PD-1) inhibitors plus apatinib chemotherapy (PAC) in patients with locally advanced gastric cancer (LAGC).Seventy-three resectable LAGC were enrolled named PAC group (n=39) or (AC) (n=34) based on treatment they chose. Neoadjuvant therapy was administered a 21-day cycle for 3 consecutive cycles, after which surgery performed.The exhibited higher objective response rate than AC (74.4% vs. 58.8%,...

10.5230/jgc.2023.23.e17 article EN Journal of the Korean Gastric Cancer Association 2023-01-01
Coming Soon ...